Posted by: 2in10 | 04/13/2011

human cells produced

Today’s Boston Herald reported in the business section that the field of regenerative medicine, coming out of work at MIT, is booming in Massachusetts. The news is that Organogenesis, Inc. is expanding in Mass. and building a nearly 100,000 SF facility to manufacture human cells in Canton for $63 million.

CEO Jeff MacKay is quoted as saying, “There’s a lot of ground-breaking science that’s happening in Petri dishes in labs and academic institutions around the world, but we take that cell biology and mass-produce it.”

Organogenesis’s best known application is Appligraf, described as “a hockey puck-sized product comprised of 10 million young, living cells used to heal open wounds of diabetic and others that fail to heal on their own.” Often amputations are avoided with this treatment.

This gives us hope for other innovations that will defuse and cure cancer.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: